M. Lucas

bladder in multiple sclerosis A UK consensus on the management of the

M. Drake, J. Mangnall, J. Panicker, 2009 .

A UK consensus on the management of the bladder in multiple sclerosis

C. Fowler, M. Drake, J. Mangnall, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

Effectiveness of adalimumab for refractory serpiginous choroiditis.

M. Lucas, M. Soto, Ana Chinchurreta Capote, 2014 .

Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis

G. Izquierdo Ayuso, P. Menéndez-Valladares, C. Bermudo Guitarte, 2015, Multiple sclerosis journal - experimental, translational and clinical.

Preferences for Multiple Sclerosis Treatments: Using a Discrete-Choice Experiment to Examine Differences Across Subgroups of US Patients.

A. Hauber, C. Mansfield, D. Gebben, 2017, International journal of MS care.

P504 Effectiveness and adverse events of azathioprine in inflammatory bowel disease: 9-year follow-up study

F. Bermejo, A. Algaba, A. Zapatero, 2014 .

A UK consensus on the management of the bladder in multiple sclerosis.

C. Fowler, M. Drake, J. Mangnall, 2009, Journal of neurology, neurosurgery, and psychiatry.

Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.

K. Mees, M. Grosclaude, M. Pinelli, 1997, Rhinology.

A UK consensus on the management of the bladder in multiple sclerosis

C. Fowler, M. Drake, J. Mangnall, 2009, Journal of Neurology, Neurosurgery, and Psychiatry.